Poor awareness of infection among individuals testing positive for HCV | ||||
A study in the most recent issue of Hepatology examines awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C. | ||||
Many persons infected with hepatitis C virus (HCV) are unknown to the healthcare system because they may be asymptomatic for years, have not been tested for HCV infection, and only seek medical care when they develop liver-related complications. Dr Maxine Denniston and colleagues from Georgia, USA analyzed data from persons who tested positive for past or current HCV infection during participation in the National Health and Nutrition Examination Survey (NHANES) from 2001 through 2008. A follow-up survey was conducted 6 months after examination to determine how many participants testing positive for HCV infection were aware of their HCV status before being notified by NHANES.
Of 30,140 participants tested, 1% had evidence of past or current HCV infection, and 43% could be contacted during the follow-up survey and interviewed. Only 50% were aware of their positive HCV infection status before being notified by NHANES, and only 4% of these respondents reported that they had first been tested for HCV because they or their doctor thought they were at risk for infection. The team observed that 85% had heard of hepatitis C. Correct responses to questions about hepatitis C were higher among persons 40-59 years of age, white non-Hispanics, and respondents who saw a physician after their first positive HCV test. The researchers noted that 80% of respondents indicated they had seen a doctor about their first positive HCV test result. Dr Denniston's team commented, "These data indicate that fewer than half of those infected with HCV may be aware of their infection." "The findings suggest that more intensive efforts are needed to identify and test persons at risk for HCV infection."
|
This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
No comments:
Post a Comment